ethinylestradiol-3-sulfate has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dörner, G; Guddat, HM; Rhode, W; Schnorr, D; Stahl, F | 1 |
| Drawz, B; Drawz, G; Hoffmann, L; Russbüldt, R | 1 |
2 other study(ies) available for ethinylestradiol-3-sulfate and Adenocarcinoma
| Article | Year |
|---|---|
[Clinical study of ethinyl estradiol sulfonate in conservative therapy of prostate cancer].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Combined Modality Therapy; Drug Implants; Ethinyl Estradiol; Humans; Luteinizing Hormone; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone | 1987 |
[Experiences in the treatment of advanced prostatic cancer using Turisteron with special reference to cardiovascular complications].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma; Cardiovascular Diseases; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk | 1987 |